Market Overview

Invacare Corporation Appoints Barbara Bodem to Board of Directors


Invacare Corporation (NYSE:IVC) today announced the appointment of
Barbara W. Bodem to its Board of Directors, effective August 18, 2017.
Ms. Bodem has served as senior vice president of finance for
Mallinckrodt plc (NYSE:MNK), a global specialty pharmaceutical company,
since October 2015.

With more than 20 years of corporate finance experience at leading
pharmaceutical and medical device companies, Ms. Bodem offers strong
finance, senior management and industry expertise. Her appointment
brings the number of Invacare directors to a total of eight, seven of
whom are considered independent directors.

"We are excited to welcome Barbara to the Invacare Board of Directors.
Barbara is an accomplished business leader with outstanding experience
at global pharmaceutical and medical device companies, which will enable
her to provide insight and counsel to our company and fellow Board
members," said Matthew E. Monaghan, chairman, president and chief
executive officer. "I am pleased to be growing our board with strong
leaders who bring deep medical, commercial and business experience to
guide us for the future. Barbara will be a great addition to our already
strong board."

"I am excited to join the Invacare Board of Directors and to be part of
the next phase of the company's transformation and growth. I look
forward to working with Matt Monaghan, Dr. Martin Harris, lead director,
and my talented colleagues on the Board, to realize Invacare's strategic
vision," said Ms. Bodem.

Prior to joining Mallinckrodt, Ms. Bodem served as vice president,
global commercial finance for Hospira (NYSE:HSP), a global
pharmaceutical and medical device company, from October 2013 to
September 2015. Prior to that, Ms. Bodem served in a variety of
financial roles both in the United States and United Kingdom for Eli
Lilly and Company (NYSE:LLY). Her most recent role at Eli Lilly was
chief financial officer for the Lilly Oncology business. Ms. Bodem
received both her B.S. and M.B.A degrees from Indiana University.

About Invacare Corporation

Invacare Corporation (NYSE:IVC) is a leading manufacturer and
distributor in its markets for medical equipment used in non-acute care
settings. At its core, the company designs, manufactures and distributes
medical devices that help people to move, breathe, rest, and perform
essential hygiene. The company provides medical device solutions for
congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida),
acquired (e.g., stroke, spinal cord injury, traumatic brain injury,
post-acute recovery, pressure ulcers) and degenerative (e.g., ALS,
multiple sclerosis, chronic obstructive pulmonary disease (COPD),
elderly, bariatric) ailments. The company's products are important parts
of care for people with a wide range of challenges, from those who are
active and heading to work or school each day and may need additional
mobility or respiratory support, to those who are cared for in
residential care settings, at home, and in rehabilitation centers. The
company sells its products principally to home medical equipment
providers with retail and e-commerce channels, residential care
operators, distributors, and government health services in North
America, Europe, and Asia/Pacific. For more information about the
company and its products, visit Invacare's website at

View Comments and Join the Discussion!